Chinese biotech firm Vcanbio Cell & Gene Engineering Corporation has led a series B round in Genetron Health, a Beijing-based cancer genomics solutions start-up. New Horizon Capital and existing investors Shenzhen Share Capital Partners, Yueyin Venture and others also participated in the round, which is reportedly worth hundreds of millions RMB. The company says it […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.